Sort
130,381 grants matching “hiv”
NEVIRAPINE+ZIDOVUDINE--PREVENT PERINATAL HIV IN THAILAND
$1,044,972Harvard University (Sch Of Public Hlth) · R01 · FY2002 · HD
Gene Therapy for SCID-X1 using a self-inactivating (SIN) gammaretroviral vector
$1,044,958David A Williams · Boston Children'S Hospital · U01 · FY2011 · AI
Host Defense Regulation and Viral Oncogenesis
$1,044,934Glen N. Barber · University Of Miami School Of Medicine · P01 · FY2013 · CA
WIHS VIROLOGIC RESISTANCE AND REBOUND STUDY
$1,044,744University Of California San Francisco · R01 · FY2001 · AI
Adjustment Problems and Substance Use in 3 Generations
$1,044,653Oregon Social Learning Center, Inc. · R01 · FY2005 · DA
Postmortem Pathology
$1,044,285David Erwin Kleiner · Division Of Basic Sciences - Nci · ZIC · FY2025 · CA
Alphavirus Replicon Vaccines to Encephalitis Viruses
$1,044,172Jonathan Smith · Alphavax Human Vaccines, Inc. · U01 · FY2006 · AI
ENHANCED HIV COMMUNITY PLANNING IN THE DISTRICT
$1,043,819Nnemdi Kamanu-Elias · Dc Department Of Health · U65 · FY2011 · PS
NIMH Multisite HIV/STD Prevention Trial for African-American Couples
$1,043,767Gail E Wyatt · University Of California Los Angeles · U10 · FY2007 · MH
Center for Novel Therapeutics for HIV Associated Cognitive Disorders-Animal Core
$1,043,591Justin C McArthur · Johns Hopkins University · P30 · FY2009 · MH
VERMONT IMMUNOBIOL/INFECTIOUS DIS CTR: CORE A: ADMINISTRATIVE/INTELLECTUAL CORE
$1,043,361Ralph C. Budd · University Of Vermont & St Agric College · P20 · FY2008 · RR
Adjustment Problems and Substance Use in 3 Generations
$1,043,317Deborah M. Capaldi · Oregon Social Learning Center, Inc. · R01 · FY2011 · DA
PWID Opportunities to Improve TrEat and Retain (POINTER)
$1,043,280Gregory M Lucas · Johns Hopkins University · R01 · FY2022 · DA
Monitoring SIV Reservoirs with Whole Body immunoPET
$1,043,190Francois J Villinger · University Of Louisiana At Lafayette · R01 · FY2016 · AI
Epigenetic & Post-Translational Mechanisms of Macrophage Resistance to Mycobacterium tuberculosis During HIV Co-Infection
$1,043,172Thomas R Hawn · University Of Washington · R61 · FY2019 · AI
Peer-based Retention of people who Use Drugs in Rural Research (PROUD-R2)
$1,043,102Philip Todd Korthuis · Oregon Health & Science University · U01 · FY2018 · TR
NeuroAIDS Therapeutics-Targeting Immune Polarization of Macrophages in CNS
$1,042,975Jay Rappaport · Temple Univ Of The Commonwealth · P01 · FY2015 · MH
Biomedical Informatics Training Program at Stanford
$1,042,967Sylvia Katina Plevritis · Stanford University · T15 · FY2024 · LM
Optimizing PrEP adherence in sexual minority men who use stimulants
$1,042,929Adam Wayne Carrico · University Of Miami School Of Medicine · R01 · FY2021 · DA
Optimizing PrEP adherence in sexual minority men who use stimulants
$1,042,929Adam Wayne Carrico · University Of Miami School Of Medicine · R01 · FY2022 · DA
Characterization of HIV-1 IgA bNAbs and ADCP function
$1,042,788Xueling Wu · Columbia University Health Sciences · R01 · FY2024 · AI
Vaccine and immunotherapy strategies for cancer and viruses causing cancer
$1,042,696Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2021 · CA
Molecular Analysis Of Retroviral Genes And Their Products
$1,042,653Klaus Strebel · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
CMV Immunotherapeutic Vaccine
$1,042,445Vical, Inc. · R44 · FY2005 · AI
Search for the Structural Basis of Biomacromolecular Function and Activity
$1,042,358Yun Xing M Wang · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA